Primary and secondary antibodies to power up your experiments, please contact us at the email below to order.
Email us at catalogue@floweighteen38.pt with the subject line “Antibody Catalogue”.
We will reply to your query as soon as possible and always within 24 hours.
| Catalogue number | Catalogue name |
| 000103 | Anti-SOST Antibody (Setrusumab) |
| 000137 | Anti-CFD Antibody (Lampalizumab) |
| 000141 | Anti-GDF-8 Antibody (Trevogrumab) |
| 000151 | Anti-GDF-8/Myostatin Antibody (Landogrozumab) |
| 000166 | Anti-Sclerostin Antibody (Romosozumab) |
| 000211 | Anti-SOST Antibody (Blosozumab) |
| 000244 | Anti-VEGF-A Antibody (Ranibizumab) |
| Catalogue number | Catalogue name |
| 000001 | Anti-C5 Antibody (Ravulizumab) |
| 000002 | Anti-CD221 Antibody (Teprotumumab) |
| 000003 | Anti-CD3 Antibody (Teplizumab) |
| 000004 | Anti-IL-12 and IL-23 Antibody (Briakinumab) |
| 000005 | Anti-IL-12 and IL-23 Antibody (Ustekinumab) |
| 000006 | Anti-IL-23 Antibody (Brazikumab) |
| 000007 | Anti-TNFα Antibody (Adalimumab) |
| 000038 | Anti-BAFF Antibody (Tabalumab) |
| 000052 | Anti-IL-13 Antibody (Dectrekumab) |
| 000053 | Anti-CD20 Antibody (Ublituximab) |
| 000055 | Anti-CD3ε Antibody (Muromonab) |
| 000057 | Anti-TNFα Antibody (Golimumab) |
| 000060 | Anti-INN Antibody (Sifalimumab) |
| 000062 | Anti-CD25 Antibody (Basiliximab) |
| 000072 | Anti-LPAM Antibody (Abrilumab) |
| 000073 | Anti-IL-1β Antibody (Canakinumab) |
| 000076 | Anti-IFNAR Antibody (Anifrolumab) |
| 000080 | Anti-CD3ε Antibody (Otelixizumab) |
| 000084 | Anti-IL-23 Antibody (Guselkumab) |
| 000093 | Anti-LINGO-1 Antibody (Opicinumab) |
| 000094 | Anti-IL-6R Antibody (Sarilumab) |
| 000095 | Anti-AOC-3 Antibody (Timolumab) |
| 000096 | Anti-CD40 Antibody (Bleselumab) |
| 000101 | Anti-BAFF receptor Antibody (Ianalumab) |
| 000107 | Anti-CD3ε Antibody (Foralumab) |
| 000115 | Anti-CXCL10/IP-10 Antibody (Eldelumab) |
| 000117 | Anti-GM-CSF receptor α Antibody (Mavrilimumab) |
| 000126 | Anti-TNFα Antibody (Infliximab) |
| 000133 | Anti-IL-17A Antibody (Secukinumab) |
| 000155 | Anti-CD25 Antibody (Daclizumab) |
| 000167 | Anti-IL-17 Antibody (Bimekizumab) |
| 000168 | Anti-FCGRT Antibody (Rozanolixizumab) |
| 000169 | Anti-IL-22 Antibody (Fezakinumab) |
| 000172 | Anti-CD3 Receptor Antibody (Visilizumab) |
| 000176 | Anti-CCR2 Antibody (Plozalizumab) |
| 000177 | Anti-IL-23 Antibody (Tildrakizumab) |
| 000181 | Anti-ITGA4 Antibody (Etrolizumab) |
| 000183 | Anti-CD19 Antibody (Inebilizumab) |
| 000185 | Anti-RTN4 Antibody (Ozanezumab) |
| 000188 | Anti-IL-17A Antibody (Ixekizumab) |
| 000193 | Anti-MS4A1 Antibody (Ocrelizumab) |
| 000197 | Anti-C5 Antibody (Eculizumab) |
| 000201 | Anti-IL-23α Antibody (Mirikizumab) |
| 000202 | Anti-RHD Antibody (Roledumab) |
| 000203 | Anti-IL-6 receptor Antibody (Tocilizumab) |
| 000205 | Anti-Integrin α4β7 Antibody (Vedolizumab) |
| 000209 | Anti-α4 Integrin Antibody (Natalizumab) |
| 000210 | Anti-BAFF, Blys Antibody (Belimumab) |
| 000212 | Anti-IL-6 Antibody (Clazakizumab) |
| 000220 | Anti-Integrin α 2 Antibody (Vatelizumab) |
| 000221 | Anti-TNF α Antibody (Certolizumab) |
| 000224 | Anti-IL-6 receptor Antibody (Satralizumab) |
| 000236 | Anti-IFN-α Antibody (Rontalizumab) |
| 000237 | Anti-CD11a Antibody (Efalizumab) |
| 000243 | Anti-LT-α Antibody (Pateclizumab) |
| 000008 | Anti-CD20 Antibody (Ofatumumab) |
| 000009 | Anti-CD20 Antibody (Rituximab) |
| 000056 | Anti-CD4 Antibody (Zanolimumab) |
| 000066 | Anti-MCP-1 Antibody (Carlumab) |
| 000225 | Anti-CD22 Antibody (Epratuzumab) |
| 000240 | Anti-CD52 Antibody (Alemtuzumab) |
| 000179 | Anti-IL-1B Antibody (Gevokizumab) |
| Catalogue number | Catalogue name |
| 000010 | Anti-CD137 Antibody (Urelumab) |
| 000011 | Anti-CD137 Antibody (Utomilumab) |
| 000012 | Anti-CD20 Antibody (Obinutuzumab) |
| 000013 | Anti-CD221 Antibody (Cixutumumab) |
| 000014 | Anti-CD221 Antibody (Dalotuzumab) |
| 000015 | Anti-CD221 Antibody (Figitumumab) |
| 000016 | Anti-CD221 Antibody (Ganitumab) |
| 000017 | Anti-CD221 Antibody (Robatumumab) |
| 000018 | Anti-CD274 Antibody (Durvalumab) |
| 000019 | Anti-CD30 Antibody (Brentuximab Vedotin) |
| 000020 | Anti-CD38 Antibody (Daratumumab) |
| 000021 | Anti-CSF1 Antibody (Lacnotuzumab) |
| 000022 | Anti-CTLA-4 Antibody (Ipilimumab) |
| 000023 | Anti-EGFR Antibody (Cetuximab) |
| 000024 | Anti-EGFR Antibody (Panitumumab) |
| 000025 | Anti-PD-1 Antibody (Pembrolizumab) |
| 000026 | Anti-PD-L1 Antibody (Atezolizumab) |
| 000027 | Anti-VEGF-A Antibody (Bevacizumab) |
| 000035 | Anti-Nectin-4 Antibody (Enfortumab) |
| 000036 | Anti-CTLA-4 Antibody (Tremelimumab) |
| 000037 | Anti-NGNA ganglioside Antibody (Racotumomab) |
| 000039 | Anti-ACVRL1 Antibody (Ascrinvacumab) |
| 000040 | Anti-HGF Antibody (Rilotumumab) |
| 000041 | Anti-HER3 Antibody (Patritumab) |
| 000042 | Anti-Human Histone Antibody (Derlotuximab) |
| 000043 | Anti-CLDN18.2 Antibody (Zolbetuximab) |
| 000045 | Anti-ENG Antibody (Carotuximab) |
| 000046 | Anti-VEGFR2 Antibody (Ramucirumab) |
| 000047 | Anti-CD27 Antibody (Varlilumab) |
| 000048 | Anti-HER1 Antibody (Futuximab) |
| 000050 | Anti-ILGF2 Antibody (Dusigitumab) |
| 000054 | Anti-EGFR Antibody (Necitumumab) |
| 000059 | Anti-EGFR Antibody (Zalutumumab) |
| 000061 | Anti-Fibronectin Antibody (Radretumab) |
| 000063 | Anti-Phosphatidylserine Antibody (Bavituximab) |
| 000064 | Anti-HER1 Antibody (Modotuximab) |
| 000068 | Anti-GC-C Antibody (Indusatumab) |
| 000069 | Anti-KIR2DL1/2/3 Antibody (Lirilumab) |
| 000071 | Anti-F3 Antibody (Tisotumab) |
| 000074 | Anti-PDGF-Rα Antibody (Tovetumab) |
| 000075 | Anti-IL-6 Antibody (Siltuximab) |
| 000078 | Anti-GPNMB Antibody (Glembatumumab) |
| 000081 | Anti-HER3 Antibody (Seribantumab) |
| 000082 | Anti-CD30 Antibody (Iratumumab) |
| 000085 | Anti-MUC16 Antibody (Abagovomab) |
| 000086 | Anti-CA-IX Antibody (Girentuximab) |
| 000089 | Anti-Mesothelin Antibody (Anetumab) |
| 000091 | Anti-HGFR Antibody (Emibetuzumab) |
| 000092 | Anti-VEGFR-1 Antibody (Icrucumab) |
| 000100 | Anti-Integrin Alpha-V Antibody (Intetumumab) |
| 000102 | Anti-EGFR Antibody (Tomuzotuximab) |
| 000104 | Anti-SLAMF7 Antibody (Elotuzumab) |
| 000105 | Anti-MUC5AC Antibody (Ensituximab) |
| 000111 | Anti-PD-L1 Antibody (Avelumab) |
| 000112 | Anti-PD-1 Antibody (Camrelizumab) |
| 000114 | Anti-DR5 Antibody (Drozitumab) |
| 000119 | Anti-Notch 2/3 Antibody (Tarextumab) |
| 000120 | Anti-TNFRSF10B Antibody (Tigatuzumab) |
| 000122 | Anti-Mesothelin Antibody (Amatuximab) |
| 000123 | Anti-SDC1 Antibody (Indatuximab) |
| 000124 | Anti-CD56 Antibody (Lorvotuzumab) |
| 000125 | Anti-PD-1 Antibody (Nivolumab) |
| 000132 | Anti-PDGF-Rα Antibody (Olaratumab) |
| 000142 | Anti-HER2 Antibody (Margetuximab) |
| 000143 | Anti-FRα Antibody (Mirvetuximab) |
| 000146 | Anti-GD2 Antibody (Dinutuximab) |
| 000149 | Anti-αVβ3 integrin Antibody (Etaracizumab) |
| 000152 | Anti-CD37 Antibody (Otlertuzumab) |
| 000156 | Anti-CD80 Antibody (Galiximab) |
| 000157 | Anti-PD-1 Antibody (Tislelizumab) |
| 000158 | Anti-DLL3 Antibody (Rovalpituzumab) |
| 000159 | Anti-CTGF Antibody (Pamrevlumab) |
| 000160 | Anti-CD19 Antibody (Coltuximab) |
| 000161 | Anti-CD38 Antibody (Isatuximab) |
| 000163 | Anti-CD33 Antibody (Lintuzumab) |
| 000164 | Anti-EGFR Antibody (Imgatuzumab) |
| 000173 | Anti-CD20 Antibody (Veltuzumab) |
| 000174 | Anti-GPC3 Antibody (Codrituzumab) |
| 000175 | Anti-CCR4 Antibody (Mogamulizumab) |
| 000180 | Anti-Trop-2 Antibody (Sacituzumab) |
| 000184 | Anti-SLC34A2 Antibody (Lifastuzumab) |
| 000187 | Anti-HER2/neu Antibody (Trastuzumab) |
| 000189 | Anti-CD51 Antibody (Abituzumab) |
| 000190 | Anti-EGFR Antibody (Matuzumab) |
| 000198 | Anti-HGF Antibody (Ficlatuzumab) |
| 000200 | Anti-CD23 Antibody (Lumiliximab) |
| 000204 | Anti-CD22 Antibody (Pinatuzumab) |
| 000206 | Anti-HER3 Antibody (Duligotuzumab) |
| 000208 | Anti-CD33 Antibody (Vadastuximab) |
| 000214 | Anti-HER2 Antibody (Pertuzumab) |
| 000216 | Anti-CD22 Antibody (Inotuzumab) |
| 000218 | Anti-EGFR Antibody (Depatuxizumab) |
| 000227 | Anti-FRA Antibody (Farletuzumab) |
| 000228 | Anti-MET Antibody (Onartuzumab) |
| 000231 | Anti-EGFL-7 Antibody (Parsatuzumab) |
| 000232 | Anti-CD79B Antibody (Polatuzumab) |
| 000233 | Anti-PD-1 Antibody (Spartalizumab) |
| 000234 | Anti-OX40 Antibody (Vonlerolizumab) |
| 000235 | Anti-CD33 Antibody (Gemtuzumab) |
| 000239 | Anti-CD40 Antibody (Dacetuzumab) |
| 000241 | Anti-EGFR Antibody (Nimotuzumab) |
| 000246 | Anti-TEM1 Antibody (Ontuxizumab) |
| 000113 | Anti-RANK ligand Antibody (Denosumab) |
| 000170 | Anti-TFGβ 1/2/3 Antibody (Fresolimumab) |
| 000219 | Anti-PD-1 Antibody (Pidilizumab) |
| 000194 | Anti-MMP9 Antibody (Andecaliximab) |
| Catalogue number | Catalogue name |
| 000028 | Anti-PCSK9 Antibody (Bococizumab) |
| 000067 | Anti-Selectin P Antibody (Inclacumab) |
| 000097 | Anti-PCSK9 Antibody (Evolocumab) |
| 000116 | Anti-ANGPTL3 Antibody (Evinacumab) |
| 000128 | Anti-PCSK9 Antibody (Alirocumab) |
| 000171 | Anti-PCSK9 Antibody (Lodelcizumab) |
| 000215 | Anti-Selectin P Antibody (Crizanlizumab) |
| Catalogue number | Catalogue name |
| 000044 | Anti-IL-17Rα Antibody (Brodalumab) |
| 000049 | Anti-HNGF Antibody (Fasinumab) |
| 000070 | Anti-C5 Antibody (Tesidolumab) |
| 000079 | Anti-GM-CSF Antibody (Lenzilumab) |
| 000098 | Anti-NGF Antibody (Fulranumab) |
| 000099 | Anti-IL-13 Antibody (Tralokinumab) |
| 000106 | Anti-CD6 Antibody (Itolizumab) |
| 000108 | Anti-TSLP Antibody (Tezepelumab) |
| 000109 | Anti-IL-13 Antibody (Anrukinzumab) |
| 000134 | Anti-oxLDL Antibody (Orticumab) |
| 000138 | Anti-C5a Antibody (Olendalizumab) |
| 000140 | Anti-IL-4 receptor α Antibody (Dupilumab) |
| 000145 | Anti-IGHE Antibody (Quilizumab) |
| 000148 | Anti-IL-9 Antibody (Enokizumab) |
| 000150 | Anti-Kallikrein Antibody (Lanadelumab) |
| 000153 | Anti-IL-20 Antibody (Fletikumab) |
| 000191 | Anti-IL-6 Antibody (Olokizumab) |
| 000192 | Anti-IL-6 Antibody (Sirukumab) |
| 000213 | Anti-IGHE Antibody (Ligelizumab) |
| 000222 | Anti-IL-13 Antibody (Lebrikizumab) |
| 000223 | Anti-IL-23α Antibody (Risankizumab) |
| 000226 | Anti-CD125 Antibody (Benralizumab) |
| 000229 | Anti-IL-5 Antibody (Reslizumab) |
| 000238 | Anti-CD4 Antibody (Tregalizumab) |
| 000242 | Anti-IgE Fc region Antibody (Omalizumab) |
| 000245 | Anti-IL-5 Antibody (Mepolizumab) |
| Catalogue number | Catalogue name |
| 000030 | Anti-RSV glycoprotein F Antibody (Motavizumab) |
| 000051 | Anti-Rabies Virus Glycoprotein Antibody (Foravirumab) |
| 000058 | Anti-Staphylococcus aureus α toxin Antibody (Suvratoxumab) |
| 000065 | Anti-Clostridium difficile toxin B Antibody (Bezlotoxumab) |
| 000087 | Anti-Stx1B Antibody (Pritoxaximab) |
| 000090 | Anti-TcdA Antibody (Berlimatoxumab) |
| 000110 | Anti-Staphylococcus aureus Antibody (Atidortoxumab) |
| 000127 | Anti-E. Coli Stx2A Antibody (Setoxaximab) |
| 000139 | Anti-Rabies Glycoprotein Antibody (Rafivirumab) |
| 000144 | Anti-Anthrax Antibody (Obiltoxaximab) |
| 000147 | Anti-C Diff. Toxin A Antibody (Actoxumab) |
| 000162 | Anti-CD4 Antibody (Ibalizumab) |
| 000165 | Anti-P. aeruginosa Antibody (Panobacumab) |
| 000182 | Anti-IAV HA Antibody (Gedivumab) |
| 000195 | Anti-RSF protein F Antibody (Palivizumab) |
| Catalogue number | Catalogue name |
| 000088 | Anti-Amyloid beta Antibody (Aducanumab) |
| 000118 | Anti-Amyloid beta Antibody (Solanezumab) |
| 000129 | Anti-Amyloid beta Antibody (Bapineuzumab) |
| 000130 | Anti-CGRPR Antibody (Erenumab) |
| 000131 | Anti-Amyloid beta Antibody (Gantenerumab) |
| 000135 | Anti-Amyloid beta Antibody (Crenezumab) |
| 000154 | Anti-MAG Antibody (Refanezumab) |
| 000186 | Anti-APP Antibody (Ponezumab) |
| 000199 | Anti-CALCA, CALCB Antibody (Galcanezumab) |
| 000207 | Anti-CALCA/CALCB Antibody (Eptinezumab) |
| 000217 | Anti-CGRP α/β Antibody (Fremanezumab) |
| Catalogue number | Catalogue name |
| 000178 | Anti-LOXL2 Antibody (Simtuzumab) |
| 000029 | Anti-IFNγ Antibody (Emapalumab) |
| 000136 | Anti-TFPI Antibody (Concizumab) |
| 000077 | Anti-GDF-8 Antibody (Domagrozumab) |
| 000121 | Anti-ACVR2B Antibody (Bimagrumab) |
| 000196 | Anti-NGF Antibody (Tanezumab) |
| 000230 | Anti-Dabigatran Antibody (Idarucizumab) |
| 000083 | Anti-FGF 23 Antibody (Burosumab) |
| Catalogue number | Catalogue name |
| 000031 | Anti-FLAG-2H8 |
| 000032 | Anti-HiS-3D5 |
| 000033 | Anti-Ki-67 |
| 000034 | Anti-cMyc |
All listed antibodies are for Research Use Only, use in any diagnostic or therapeutic application is not permitted.
Reference Rx Antibodies are offered under the “Bolar Exemption”, customers are solely responsible for ensuring their use of these products is strictly compliant with all relevant regulations, and does not infringe on any applicable intellectual property rights.